The European Medicines Agency (EMA), plans to decide on whether to recommend the vaccine against Covid-19 made by US pharmaceutical manufacturer Johnson and Johnson on March 11, it said on Tuesday.
The EMA’s committee for human medicine is expected to approve the jab for use in the European Union after an extraordinary meeting.
The European Commission would then have to approve the step, but this is a formality that could take place the same day.
EMA experts are already reviewing company data drawn from trials and studies. The United States approved the active ingredient for use over the weekend.
The jab was developed by the company’s subsidiary Janssen in the Netherlands. Unlike other vaccines, only one dose is required.
So far, three vaccines are approved for use in the EU – by Moderna, Pfizer/BioNTech and AstraZeneca.